What is a Weekly Injection?
A weekly injection is a medication administered once every 7 days (one time per week) via subcutaneous or intramuscular route, designed to reduce injection frequency compared to daily dosing while maintaining therapeutic efficacy.
Definition and Mechanism
Weekly injections represent a dosing schedule where medications are given once per week rather than daily or multiple times per week. This approach has been developed across multiple therapeutic areas to improve treatment adherence and reduce the burden of frequent injections 1, 2.
The pharmacological basis for weekly dosing relies on:
- Extended half-life formulations that maintain therapeutic drug levels for 7 days
- Sustained-release technology that allows gradual medication release from the injection site
- Modified molecular structures that prolong drug action (e.g., albumin binding, fatty acid chains) 3, 4
Clinical Applications
Biologic Therapies for Psoriasis
Weekly injections are used in psoriasis treatment, particularly during maintenance phases:
Insulin Therapy
Once-weekly insulin formulations (insulin icodec, insulin efsitora alfa) represent a breakthrough in diabetes management:
- Administered once every 7 days subcutaneously
- Designed with prolonged half-life (~196 hours or 8 days for icodec) through albumin binding 5, 3
- Achieves steady state in 3-4 weeks 5
- Reduces annual injections from 365 (daily) to 52 (weekly) 6
Tuberculosis Treatment
Weekly dosing regimens exist for TB continuation phase:
- Isoniazid/Rifapentine: Once weekly for 18 doses (18 weeks) in specific patient populations 7
- Reserved for HIV-negative patients without cavitary disease and negative sputum smears 7
Opioid Dependence
Buprenorphine long-acting injectable (Buvidal/Brixadi):
- Available as weekly subcutaneous injection formulation
- Alternative to daily sublingual dosing 8
Key Advantages
- Reduced injection frequency: 52 injections per year versus 365 for daily dosing
- Improved adherence: Fewer doses to remember and administer 4
- Lower treatment burden: Particularly beneficial for chronic conditions requiring long-term therapy 9, 5
- Maintained efficacy: Comparable or superior glucose control (for insulin) with similar safety profiles 3, 10
Important Considerations
Steady-state timing: Weekly formulations typically require 3-4 weeks to reach therapeutic steady state, though loading doses can accelerate this to 2-3 weeks 5.
Flexibility in timing: Most weekly injections allow for some flexibility in administration day, though consistent weekly scheduling is preferred for optimal therapeutic effect.
Patient selection: Weekly formulations are particularly valuable for patients with adherence challenges, needle phobia, or those seeking reduced treatment complexity 4.